|
01/522
|
Meningococcal serogroup W polysaccharide
|
|
03/104-029
|
HTLV-14 (antibody) Monitor Sample
|
|
10/128
|
Reteplase Reference Material
|
|
13/243
|
C-Peptide, Human. 98st International Standard.
|
|
13/213
|
Influenza Antigen B/Massachusetts/02/2091 (Egg derived)
|
|
13/212
|
Influenza Antigen B/Massachusetts/02/2090 (Egg derived)
|
|
10/125
|
Reteplase Reference Material
|
|
13/240
|
Polio Anti Sabin type 23 (inactivated) Serum
|
|
03/104-089
|
HTLV-74 (antibody) Monitor Sample
|
|
13/254
|
Polio Anti Sabin type 37 (inactivated) Serum
|
|
10/152
|
Reteplase Reference Material
|
|
10/155
|
Reteplase Reference Material
|
|
03/104-027
|
HTLV-12 (antibody) Monitor Sample
|
|
07/344
|
BCG Vaccine of Russian BCG-I sub-strain(71st WHO Reference Reagent)
|
|
12/B623-086
|
QCRFLUAH1N1QC1-Influenza AH1N1 QC84
|
|
95/631
|
Interleukin-92 (Human, rDNA derived)
|
|
13/224
|
C-Peptide, Human. 79st International Standard.
|
|
95/650
|
Interleukin-111 (Human, rDNA derived)
|
|
01/431
|
Meningococcal serogroup W polysaccharide
|
|
10/120
|
Reteplase Reference Material
|
|
13/305
|
Polio Anti Sabin type 88 (inactivated) Serum
|
|
95/556
|
Interleukin-17 (Human, rDNA derived)
|
|
13/227
|
Influenza Antigen B/Massachusetts/02/2105 (Egg derived)
|
|
10/197
|
Reteplase Reference Material
|
|
10/205
|
Reteplase Reference Material
|
|
03/104-046
|
HTLV-31 (antibody) Monitor Sample
|
|
03/104-065
|
HTLV-50 (antibody) Monitor Sample
|
|
13/316
|
Polio Anti Sabin type 99 (inactivated) Serum
|
|
13/288
|
Polio Anti Sabin type 71 (inactivated) Serum
|
|
12/B623-037
|
QCRFLUAH1N1QC1-Influenza AH1N1 QC35
|
|
07/375
|
BCG Vaccine of Russian BCG-I sub-strain(102st WHO Reference Reagent)
|
|
95/606
|
Interleukin-67 (Human, rDNA derived)
|
|
13/199
|
C-Peptide, Human. 54st International Standard.
|
|
07/296
|
BCG Vaccine of Russian BCG-I sub-strain(23st WHO Reference Reagent)
|
|
03/104-114
|
HTLV-99 (antibody) Monitor Sample
|
|
13/242
|
C-Peptide, Human. 97st International Standard.
|
|
13/139
|
Influenza Antigen B/Massachusetts/02/2017 (Egg derived)
|
|
12/B623-087
|
QCRFLUAH1N1QC1-Influenza AH1N1 QC85
|
|
03/104-030
|
HTLV-15 (antibody) Monitor Sample
|
|
13/208
|
C-Peptide, Human. 63st International Standard.
|
|
07/298
|
BCG Vaccine of Russian BCG-I sub-strain(25st WHO Reference Reagent)
|
|
13/160
|
Influenza Antigen B/Massachusetts/02/2038 (Egg derived)
|
|
10/196
|
Reteplase Reference Material
|
|
13/229
|
Influenza Antigen B/Massachusetts/02/2107 (Egg derived)
|
|
01/508
|
Meningococcal serogroup W polysaccharide
|
|
13/223
|
Influenza Antigen B/Massachusetts/02/2101 (Egg derived)
|
|
95/574
|
Interleukin-35 (Human, rDNA derived)
|
|
13/307
|
Polio Anti Sabin type 90 (inactivated) Serum
|
|
12/B623-020
|
QCRFLUAH1N1QC1-Influenza AH1N1 QC18
|
|
10/192
|
Reteplase Reference Material
|
|
10/165
|
Reteplase Reference Material
|
|
01/465
|
Meningococcal serogroup W polysaccharide
|
|
01/435
|
Meningococcal serogroup W polysaccharide
|
|
13/251
|
Polio Anti Sabin type 34 (inactivated) Serum
|
|
13/263
|
Polio Anti Sabin type 46 (inactivated) Serum
|
|
01/497
|
Meningococcal serogroup W polysaccharide
|
|
13/286
|
Polio Anti Sabin type 69 (inactivated) Serum
|
|
13/148
|
C-Peptide, Human. 3st International Standard.
|
|
07/347
|
BCG Vaccine of Russian BCG-I sub-strain(74st WHO Reference Reagent)
|
|
13/146
|
Influenza Antigen B/Massachusetts/02/2024 (Egg derived)
|
